Long term effects of azithromycin in patients with cystic fibrosis: A double blind, placebo controlled trial.
about
Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic FibrosisAntibiotics for preventing lower respiratory tract infections in high-risk children aged 12 years and underMacrolide antibiotics for cystic fibrosisMacrolide antibiotics for cystic fibrosisMacrolide antibiotics for cystic fibrosisIdentification and characterization of potential therapeutic candidates in emerging human pathogen Mycobacterium abscessus: a novel hierarchical in silico approachExacerbations in cystic fibrosis: 2 . prevention.Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosisMeasuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapyMechanisms of action and clinical application of macrolides as immunomodulatory medications.Advantages and drawbacks of long-term macrolide use in the treatment of non-cystic fibrosis bronchiectasis.Macrolides for the long-term management of asthma--a meta-analysis of randomized clinical trials.Long-term macrolide therapy in chronic obstructive pulmonary disease.Pediatric asthma: guidelines-based care, omalizumab, and other potential biologic agents.Longitudinal association between medication adherence and lung health in people with cystic fibrosis.Prophylactic use of macrolide antibiotics for the prevention of chronic obstructive pulmonary disease exacerbation: a meta-analysis.Effects of long-term use of macrolides in patients with non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled trialsThe role of macrolides in childhood non-cystic fibrosis-related bronchiectasis.Pathogen- and host-directed anti-inflammatory activities of macrolide antibioticsManagement of severe asthma in children.Influence of macrolide maintenance therapy and bacterial colonisation on exacerbation frequency and progression of COPD (COLUMBUS): study protocol for a randomised controlled trial.Effect of azithromycin on systemic markers of inflammation in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa.Tobramycin solution for inhalation in cystic fibrosis patients: a review of the literature.Recycling of peptidyl-tRNAs by peptidyl-tRNA hydrolase counteracts azithromycin-mediated effects on Pseudomonas aeruginosa.Update in cystic fibrosis 2006Advancing outcome measures for the new era of drug development in cystic fibrosis.Patient-reported outcomes in cystic fibrosisDevelopment of a population pharmacokinetic model to describe azithromycin whole-blood and plasma concentrations over time in healthy subjectsCystic fibrosis lung disease in adult patients.Lactobacillus reuteri and Escherichia coli in the human gut microbiota may predict weight gain associated with vancomycin treatmentAzithromycin for the treatment of eosinophilic nasal polyposis: Clinical and histologic analysisExacerbation rate, health status and mortality in COPD--a review of potential interventionsClinical immunology review series: An approach to the management of pulmonary disease in primary antibody deficiency.Health-related quality of life measurement in cystic fibrosis: advances and limitations.Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbations.Macrolide antibiotics and the airway: antibiotic or non-antibiotic effects?The Likelihood of Preventing Respiratory Exacerbations in Children and Adolescents with either Chronic Suppurative Lung Disease or Bronchiectasis.Challenges and advances in the development of inhalable drug formulations for cystic fibrosis lung disease.The role of anti-infectives in the treatment of refractory asthma.Targeting airway inflammation in cystic fibrosis in children: past, present, and future.
P2860
Q22306312-484691A6-3399-42AC-B95D-0D10B18DD681Q24186994-8DC7E480-19FD-4794-A851-2BB5F7964C1CQ24202885-107DC1F1-1B69-45EE-BAB0-8232B02B0431Q24234430-92C773A1-2083-4C08-A12C-EEAF1023B10AQ24247243-E325CE92-4C34-4D53-A2E5-0867509980AFQ28488335-0C22792A-E2DC-45D7-8D33-43327EE06C39Q30480308-6F78B1F8-86F8-4D9F-8054-D36A3936F217Q33637615-208F0FBE-1FE3-4AF3-9A17-7FCCBF247EACQ33697276-7548F084-B996-4BAF-85E7-955BF10A396AQ33983140-114AD94D-2472-4DE4-ABC1-276C3B508A05Q33995275-7C02A4A4-1C7D-4AC0-BF0A-8C82423902CEQ34360438-DB0B6610-212B-452B-A2DD-AA6D05D13A1BQ34373310-09472B5F-52DE-407F-BB9D-7387BA6501B4Q34625206-0BF3301F-16F4-42C7-B5D5-C91746BCED87Q35042866-69CABFC0-4722-4588-9540-9D5C851F0717Q35587748-3BCE3BBC-FBEA-46E0-9CA5-F36B0E84A28BQ35608368-AE3AC88D-0861-4045-802C-0EBFD671EEC4Q35917015-9CE81634-F4B5-4920-B885-9B55B6F4556DQ36072425-C8D66459-CAC5-4428-97FF-0A540CBE32FDQ36316775-3DCB81C9-1C95-45E3-9D80-3F0C5182F829Q36338455-8E0E15A4-302C-426A-86AD-3411CEF43F1BQ36723908-67E1E486-801E-40FF-BCA2-7A8FA4BD4AB9Q36739797-4F370C39-495B-48AF-823C-E2FF08F957CEQ36757667-980B562A-BF43-4DEF-9919-61BE28EEB2B3Q36779226-F641C98A-3D26-4DDD-AC09-DAACEBE35E42Q36891530-1C1B44E2-4C58-409E-AD53-5D13DF64364DQ36891536-5A90F975-1EE7-4E87-9485-B4945CC7FAECQ36969875-0C465AC7-3911-40DE-A667-507DD101BA2CQ37158336-5D06AC4D-AC9F-43FF-A76D-BFB7300AA4F6Q37211879-43360B34-5EDB-4F7E-9086-D69DD7A2B8F1Q37230362-986E800F-AA7B-4B14-9C91-D00FF4541B74Q37236165-98ADB4C0-FBF4-4800-BB97-196FB95B9759Q37364113-29CADBF7-354D-4E3A-BAFE-6DCB23FF5301Q37379589-6A9540A9-34F1-42C2-B644-135A06CB6080Q37449752-E264D37E-410C-469F-BCF9-7F60016069B3Q37691452-FE3878E2-33F5-43A0-93BB-3D70871ACF6AQ37718996-5E213C28-3361-4AB5-82AC-B9F7E5FE0A0AQ37849777-8099ABF9-27EB-4913-94CA-02134EF4D9E1Q37860762-52CF5FCC-98FF-4237-A656-19572EC98602Q37866284-DEE768B1-BF4D-42E3-9D83-71F15797C9EA
P2860
Long term effects of azithromycin in patients with cystic fibrosis: A double blind, placebo controlled trial.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Long term effects of azithromy ...... ind, placebo controlled trial.
@ast
Long term effects of azithromy ...... ind, placebo controlled trial.
@en
type
label
Long term effects of azithromy ...... ind, placebo controlled trial.
@ast
Long term effects of azithromy ...... ind, placebo controlled trial.
@en
prefLabel
Long term effects of azithromy ...... ind, placebo controlled trial.
@ast
Long term effects of azithromy ...... ind, placebo controlled trial.
@en
P2093
P2860
P921
P356
P1433
P1476
Long term effects of azithromy ...... ind, placebo controlled trial.
@en
P2093
P2860
P304
P356
10.1136/THX.2005.057950
P407
P577
2006-06-29T00:00:00Z